{"prompt": "['Trial ID: LP0162-1325', 'Date: 14-Aug-2018', 'Version: 4.0', 'Page 132 of 169', 'Trial monitoring', 'During the course of the trial CRA(s) will visit the trial site. These visits have the following', 'objectives: (i) to perform ongoing source data verification to confirm that data entered into the', 'CRF by authorised site personnel are accurate, complete, and verifiable from source', 'documents; (ii) to confirm that the safety and rights of subjects are being protected; and (iii)', 'to confirm that the trial is being conducted in accordance with the currently approved protocol', 'and any other study agreements, ICH GCP, and all applicable regulatory requirements.', \"The monitoring visit intervals will depend on the trial site's recruitment rate, the compliance\", 'of the trial site with the protocol and GCP.', 'In order to perform their role effectively, CRAs and persons involved in quality assurance and', 'inspections will need direct access to source data, e.g. medical records, laboratory reports,', 'appointment books, etc. If the electronic medical record does not have a visible audit trail, the', 'investigator must provide the CRA with signed and dated printouts. In addition, relevant site', 'staff should be available for discussions at monitoring visits and between monitoring visits', '(e.g. by telephone).', 'Protocol compliance', 'Protocol deviations will be documented and notified to the investigator. LEO will assess all', 'protocol deviations and decide if any of these deviations must be reported to the regulatory', 'authorities as a serious breach of GCP and the protocol, as required by local legislation.', 'Protocol deviations will be included in the CTR.', 'Sponsor audits, IRB/IEC review, and regulatory agency inspections', 'The clinical trial will be subject to audits conducted by LEO or inspections from domestic or', 'foreign regulatory authorities or from IRBs/IECs. Audits and inspections may take place', 'during or after the trial. The investigator and the site staff as well as LEO staff have an', 'obligation to cooperate and assist in audits and inspections. This includes giving auditors and', 'inspectors direct access to all source documents and other documents at the trial site relevant', 'to the clinical trial. This includes permission to examine, verify and reproduce any records', 'and reports that are important to the evaluation of the trial. If the trial site is contacted for an', 'inspection by competent authorities, LEO must be notified immediately.', 'Data handling', 'Subject data should be entered into the CRF as soon as possible after each visit in accordance', 'with the requirements described in the Clinical Trial Agreement, if applicable. Queries for', 'discrepant data will be generated automatically by the system upon entry or manually by the', 'eDoc-00631888 - Version 4.0']['Trial ID: LP0162-1325', 'Date: 14-Aug-2018', 'Version: 4.0', 'Page 133 of 169', \"CRA, sponsor's medical expert, or the data manager. All queries will be raised electronically\", 'within the electronic data capture system. This systematic validation will ensure that a clean', 'and consistent database is provided for the statistical analysis.', 'An electronic PRO (ePRO) solution will be used to capture patient-reported data (data from', 'questionnaires completed at the trial site and eDiary data). By the use of an ePRO, data will', 'be available immediately after data entry and available for monitors and site personnel,', 'including the investigator, with read access only. The ePRO system is a separate application', 'from the eCRF and data captured from the eCRF and the ePRO will be stored on different', 'servers during data capture. Data from both systems will be included in the final trial', 'database.', 'External data transfers from vendors to LEO will be transmitted and handled via a secure file', 'transfer protocol site.', 'Transmissions of electronic data from external data providers and of ePRO data to the clinical', 'database are illustrated in Panel 16.', 'Panel 16 Transmission of electronic data', 'Who', 'What', 'Where', 'Investigator/Site', 'Assessments', 'eCRF', 'entered into', 'Database', 'eCRF', 'Subject', 'Questionnaires', 'filled in using', 'ePRO', 'Database', 'ePRO/diary', 'Clinical', 'CTR', 'Laboratory', 'Database', 'LEO', 'Lab Analysis', 'Pharma', 'Lab', 'Database', 'ECG Vendor', 'ECG Analysis', 'ECG', 'Database', 'CTR, clinical trial report; ECG, electrocardiogram; eCRF, electronic case report form; ePRO,', 'electronic patient-reported outcome.', 'eDoc-00631888 - Version 4.0']\n\n###\n\n", "completion": "END"}